AtriCure, Inc.

NASDAQ:ATRC

Medical - Instruments & Supplies

Healthcare
$55.45 +3.52%

+$0.96 today

Market cap
$2.82B
Beta
1.26
P/E (TTM)
-295.5
EPS (TTM)
-$0.10
52W Low $25.36High $43.18

Volume 0.60M

Average 0.77M

ATRC Other Working Capital

Cash effect of changes in other operating assets and liabilities.

AtriCure, Inc.NASDAQ: ATRC

Other Working Capital · Q2 FY2026 · quarter ended Jun 2026

Other working capital declines year over year

Q2 FY2026 other working capital of $3.77M fell 56.4% year over year, ahead of the -151.4% change in trailing-twelve-month other working capital.

Context

  • Other working capital amounted to 0.8% of revenue in FY2025, up 0.7 pp from a year earlier.
  • Other working capital increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -56.4% holds above the trailing-twelve-month pace of -151.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$3.77M+119.6% QoQ
Last fiscal yearDec 2025
$4.54M+677.6% YoY
LTMJun 2026
-$2.63M-151.4% YoY
Other Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-56.4%——
1 year+677.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Working Capital history

USD · from the cash flow

Latest · FY2025
4.54M USD
Year-over-year change
+677.6%
4-year CAGR
-1.4%

Other Working Capital vs competitors

How ATRC compares with its peers on the latest reported figures

  • ATRC's LTM Jun 2026 other working capital of $2.63M is the smallest of the 5 companies compared; the peer median is $85.9M.
  • Its year-over-year change of -151.4% is the lowest of 5, against a peer median of -87.7%.
  • Other working capital amounts to 0.5% of revenue for ATRC, versus a peer median of 1.0%.
ATRC Competitors Peer median
Other Working Capital for ATRC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$519M -144.8%+80.1%1.4%
EWEdwards Lifesciences CorporationLTM Jun 2026$104.8M -21.0%+37.8%1.6%
BSXBoston Scientific CorporationLTM Jun 2026$67M -73.2%-25.9%0.3%
LIVNLivaNova PLCLTM Sep 2026$9.52M -102.2%+457.9%0.6%
ATRCAtriCure, Inc.LTM Jun 2026$2.63M -151.4%—0.5%
Peer median (excluding ATRC) $85.9M-87.7%+59.0%1.0%

Competitors are the stored peer set for ATRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income50.2M(46.47M)(30.44M)(44.7M)(11.45M)
Depreciation & Amortization10.44M11.71M14.81M18.73M20.53M
Deferred Income Tax84.78M0000
Stock-Based Compensation28.08M28.77M35.73M40.41M44.69M
Change in Working Capital(4.85M)(18.88M)(18.24M)(18.36M)(4.29M)
Accounts Receivables(10.09M)(8.99M)(9.87M)(8.3M)(5.61M)
Inventory(4.27M)(7.31M)(21.83M)(7.74M)(2.26M)
Accounts Payables4.71M2.68M6.18M(1.53M)(960K)
Other Working Capital4.81M(5.26M)7.29M(786K)4.54M
Other Non-Cash Items(182.43M)2.72M2.62M16.12M7.85M
Operating Cash Flow(13.78M)(22.14M)4.48M12.2M57.33M
Capital Expenditures(9.75M)(16.88M)(42M)(23.46M)(9.05M)
Acquisitions (Net)(33.26M)(44.01M)000
Purchases of Investments(173.11M)(24.64M)000
Sales of Investments206.36M85.52M63.82M00
Other Investing Activities33.26M44.01M(30M)41.69M(5.5M)
Investing Cash Flow23.5M44.01M21.82M30.23M(14.55M)
Debt Repayment(816K)(899K)(992K)(1.67M)5.05M
Common Stock Issued00007.29M
Common Stock Repurchased(18.01M)(12.2M)(6.56M)(6.95M)(11.16M)
Dividends Paid00000
Other Financing Activities11.19M6.04M7.52M5.02M0
Financing Cash Flow(7.64M)(7.06M)(32K)(3.6M)1.18M
Effect of Forex Changes(372K)(361K)(58K)(424K)747K
Net Change in Cash1.71M14.45M26.21M38.41M44.71M
Free Cash Flow(23.53M)(39.02M)(37.51M)(11.26M)48.28M

AtriCure, Inc.

NASDAQ:ATRC

Intrinsic Alpha fair value

Locked

Current Price

$55.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.